Okmetic will transfer 11,919 own shares held by the company as a part of the company's share-based incentive scheme
ET | Source:Okmetic Oyj
OKMETIC OYJ STOCK EXCHANGE RELEASE 13 FEBRUARY 2014 AT 11.40 A.M.
OKMETIC WILL TRANSFER 11,919 OWN SHARES HELD BY THE COMPANY AS A PART OF THE
COMPANY'S SHARE-BASED INCENTIVE SCHEME
Okmetic Oyj will transfer a total of 11,919 own shares held by the company as a
part of the company's share-based incentive scheme for the Executive management
group, of which the company gave a stock exchange release on 12 February 2013.
All the shares are issued to the members of the Executive management group in
deviation from the shareholders' pre-emptive rights (directed share issue).
Okmetic's Board of directors decided on 11 February 2013 on a performance-based
share reward programme for the Executive management group for 2013 as a part of
the group's incentive and commitment scheme. Okmetic's Board of directors has
confirmed in its meeting on 13 February 2014 the remuneration that shall be
granted for the earning period 1 January - 31 December 2013, based on the
realisation of the targets set in the programme. The rewards of the share reward
programme will be paid in Okmetic shares and in a monetary amount covering the
The annual general meeting of Okmetic Oyj has on 10 April 2013 authorised the
Board of directors to transfer own shares held by the company for instance
through a directed share issue.
The company's Board of directors has granted the persons participating in the
share reward programme share rewards in accordance with the terms and conditions
of the programme by means of a directed share issue without payment comprising a
total of 11,919 own shares held by the company. The directed share issue without
payment will be executed in full as there is no consideration related to the
issue. The shares will entitle to shareholders' rights when the shares have been
transferred to the shareholder. The share issue does not affect the share
capital of the company. After the share issue, the company will hold 432,204 own
shares, of which 400,000 shares through Okmetic Management Oy.
The shares earned based on the share reward programme must be held for at least
two years after the reward disbursement. In addition, the President must hold at
least half of the shares received as share reward for as long he is in the
service of the company. If a person participating in the programme ceases to be
in the service of the company, his rights based on the programme shall expire.
The persons in the programme may change during the course of the programme.
Board of directors
For further information, please contact:
Senior Vice President, Finance, IT, and Communications Juha Jaatinen, Okmetic
Oyj, tel. +358 9 5028 0286, email: firstname.lastname@example.org
NASDAQ OMX Helsinki
OKMETIC IN BRIEF
Okmetic is a technology company which supplies tailor-made silicon wafers for
sensor and semiconductor industries and sells its technological expertise.
Okmetic provides its customers with solutions that boost their competitiveness
Okmetic's silicon wafers are part of a further processing chain that produces
end products that improve human interaction and quality of life. Okmetic's
products are based on high-tech expertise that generates added value for
customers, innovative product development and an extremely efficient production
Okmetic has a global customer base and sales network, production plants in
Finland and the US and contract manufacturers in Japan and China. Okmetic's
shares are listed on NASDAQ OMX Helsinki under the code OKM1V. For more
information on the company, please visit our website at www.okmetic.com.
GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
2321 Rosecrans Avenue.
El Segundo, CA 90245 Phone: (800) 307-6627 Fax: (800) 307-3567
25 Basinghall Street,
London EC2V 5HA
UK Phone: +1 866-465-8454